WO2002002775A3 - Calpain-protease 12 - Google Patents

Calpain-protease 12 Download PDF

Info

Publication number
WO2002002775A3
WO2002002775A3 PCT/EP2001/007457 EP0107457W WO0202775A3 WO 2002002775 A3 WO2002002775 A3 WO 2002002775A3 EP 0107457 W EP0107457 W EP 0107457W WO 0202775 A3 WO0202775 A3 WO 0202775A3
Authority
WO
WIPO (PCT)
Prior art keywords
seq
capn12
calpain protease
relates
acid sequence
Prior art date
Application number
PCT/EP2001/007457
Other languages
English (en)
French (fr)
Other versions
WO2002002775A2 (de
Inventor
Thomas Boehm
Neil T Dear
Original Assignee
Basf Ag
Thomas Boehm
Neil T Dear
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag, Thomas Boehm, Neil T Dear filed Critical Basf Ag
Priority to CA002414592A priority Critical patent/CA2414592A1/en
Priority to MXPA02012647A priority patent/MXPA02012647A/es
Priority to JP2002508015A priority patent/JP2004503221A/ja
Priority to AU2001270603A priority patent/AU2001270603A1/en
Priority to EP01949449A priority patent/EP1294895A2/de
Priority to US10/312,373 priority patent/US20040072174A1/en
Publication of WO2002002775A2 publication Critical patent/WO2002002775A2/de
Publication of WO2002002775A3 publication Critical patent/WO2002002775A3/de
Priority to HK03106552.4A priority patent/HK1054407A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Calpain-Protease 12 (Capn12), dadurch gekennzeichnet, daß die eine Aminosäuresequenz, umfassend die Aminosäuren 1 - 342 der SEQ ID NO: 1 oder eine Aminosäuresequenz ausgewählt unter SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 oder SEQ ID NO: 4 aufweist; sowie deren funktionale Analoge; dafür kodierende Nukleinsäuren; rekombinante Vektoren, welche diese kodierenden Sequenzen enthalten; damit transfizierte Mikroorganismen; Verfahren zur rekombinanten Herstellung der Capn12; und verschiedene Anwendungen der Capn12 und dafür kodierender Nukleinsäuren.
PCT/EP2001/007457 2000-06-30 2001-06-29 Calpain-protease 12 WO2002002775A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA002414592A CA2414592A1 (en) 2000-06-30 2001-06-29 Calpain protease 12
MXPA02012647A MXPA02012647A (es) 2000-06-30 2001-06-29 Calpaina proteasa 12.
JP2002508015A JP2004503221A (ja) 2000-06-30 2001-06-29 カルパインプロテアーゼ１２
AU2001270603A AU2001270603A1 (en) 2000-06-30 2001-06-29 Calpain protease 12
EP01949449A EP1294895A2 (de) 2000-06-30 2001-06-29 Calpain-protease 12
US10/312,373 US20040072174A1 (en) 2000-06-30 2001-06-29 Calpain protease 12
HK03106552.4A HK1054407A1 (zh) 2000-06-30 2003-09-11 鈣蛋白酶12

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031932.7 2000-06-30
DE10031932A DE10031932A1 (de) 2000-06-30 2000-06-30 Calpain-Protease 12

Publications (2)

Publication Number Publication Date
WO2002002775A2 WO2002002775A2 (de) 2002-01-10
WO2002002775A3 true WO2002002775A3 (de) 2002-12-12

Family

ID=7647377

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007457 WO2002002775A2 (de) 2000-06-30 2001-06-29 Calpain-protease 12

Country Status (9)

Country Link
US (1) US20040072174A1 (de)
EP (1) EP1294895A2 (de)
JP (1) JP2004503221A (de)
AU (1) AU2001270603A1 (de)
CA (1) CA2414592A1 (de)
DE (1) DE10031932A1 (de)
HK (1) HK1054407A1 (de)
MX (1) MXPA02012647A (de)
WO (1) WO2002002775A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426588A1 (en) * 2000-10-26 2002-07-18 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same
US6903201B2 (en) 2001-01-05 2005-06-07 Curagen Corporation Proteins and nucleic acids encoding same
DE10244842B4 (de) 2002-09-22 2006-09-14 Stiftung Alfred-Wegener-Institut Für Polar- Und Meeresforschung Für proteinspaltende Enzyme in Form von spezifischen Proteasen kodierende Nukleinsäuresequenzen, zugehörige Polypeptide und Verwendung von allen
KR101054951B1 (ko) 2009-01-22 2011-08-05 재단법인 한국원자력의학원 간암을 진단 및 치료하기 위한 분자인 ｃａｐｎ１２, 그를 포함하는 키트

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083782A2 (en) * 2000-05-04 2001-11-08 Sugen, Inc. Novel proteases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426588A1 (en) * 2000-10-26 2002-07-18 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same
US20040063107A1 (en) * 2001-05-04 2004-04-01 Plowman Gregory D. Novel proteases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083782A2 (en) * 2000-05-04 2001-11-08 Sugen, Inc. Novel proteases

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 28 June 2000 (2000-06-28), ARAKAWA, T. ET AL.: "Mus musculus 6 days neonate skin cDNA, RIKEN full-length enriched library, clone:A030006J06, 3' end partial sequence.", XP002210216, retrieved from EBI Database accession no. BB150524 *
DATABASE SWALL [online] 1 November 1997 (1997-11-01), DEAR N. ET AL.: "(Calcium-activated neutral proteinase) (CANP) (M-type) (M-calpain) (Millimolar-calpain) (80 kDa M-calpain subunit) (CALP80).", XP002210217, retrieved from EBI Database accession no. O08529 *
DEAR N ET AL: "A NEW SUBFAMILY OF VERTEBRATE CALPAINS LACKING A CALMODULIN-LIKE DOMAIN: IMPLICATIONS FOR CALPAIN REGULATION AND EVOLUTION", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 45, no. 1, 1 October 1997 (1997-10-01), pages 175 - 184, XP002061846, ISSN: 0888-7543 *
DEAR T NEIL ET AL: "CAPN11: A calpain with high mRNA levels in testis and located on chromosome 6", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 59, no. 2, 15 July 1999 (1999-07-15), pages 243 - 247, XP002159274, ISSN: 0888-7543 *
DEAR T NEIL ET AL: "Gene structure, chromosomal localization, and expression pattern of Capn12, a new member of the calpain large subunit gene family.", GENOMICS, vol. 68, no. 2, 1 September 2000 (2000-09-01), pages 152 - 160, XP002210215, ISSN: 0888-7543 *
SAIDO T C ET AL: "CALPAIN: NEW PERSPECTIVES IN MOLECULAR DIVERSITY AND PHYSIOLOGICAL-PATHOLOGICAL INVOLVEMENT", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, vol. 8, no. 11, 1994, pages 814 - 820,822, XP002010555, ISSN: 0892-6638 *

Also Published As

Publication number Publication date
MXPA02012647A (es) 2003-09-22
AU2001270603A1 (en) 2002-01-14
DE10031932A1 (de) 2002-01-10
EP1294895A2 (de) 2003-03-26
JP2004503221A (ja) 2004-02-05
US20040072174A1 (en) 2004-04-15
HK1054407A1 (zh) 2003-11-28
CA2414592A1 (en) 2002-01-10
WO2002002775A2 (de) 2002-01-10

Similar Documents

Publication Publication Date Title
WO1998056927A3 (en) Nucleic acids encoding polypeptide having protease activity
DK1123386T3 (da) Fremgangsmåde til fremstilling af chirale carboxylsyrer af nitriler ved hjælp af en nitrilase eller mikroorganismer, som indeholder et gen for nitrilasen
WO2004099228A3 (en) Variants of beta-glucosidases
ZA967173B (en) Purified coprinus laccases and nucleic acids and encoding same
AU7550098A (en) System for expressing hyperthermostable protein
WO2002028891A3 (fr) Listeria innocua, genome et applications
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
WO2004035618A3 (en) Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
DE69615055T2 (de) Gene kodierend für ultrathermostabile proteasen
WO1996028557A3 (en) Subtilisin dy variants having decreased adsorption and increased hydrolysis
EP0857789A3 (de) Ferulasäure decarboxylase
WO2004029202A3 (en) Microbial trypsin variants having chymotrypsin activity and nucleic acids encoding same
HUP0300155A2 (en) Nitrilase from phodococcus rhodochrous ncimb 11216
WO2002002775A3 (de) Calpain-protease 12
NZ322796A (en) An apoptotic cysteine protease, mch3 which is a member of ice proteases and nucleic acids encoding mch3
AU2001273977A1 (en) Novel nucleotide sequences coding for the glbo gene
AU7655994A (en) Cloning of a member of the serine-threonine-kinase family
EP0945512A3 (de) Serinproteasen
DE60211135D1 (en) D-carbamoylase aus arthrobacter crystallopoietes dsm 20117
WO2003038105A3 (en) Sequences for the preparation of 5-ketogluconic acid from gluconic acid
MXPA04000397A (es) Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
EP0911408A3 (de) DNA kodierend für eine Serin/Threonin Kinase
CA2318490A1 (en) A novel gene for controlling leaf shapes
EP1408107A3 (de) Gen für Chlorohydrin und Hydroxycarbonsäureester asymmetrische Hydrolase
WO2001096536A3 (en) Aspartic acid proteases and nucleic acids encoding same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/012647

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2414592

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 508015

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001949449

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001949449

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10312373

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001949449

Country of ref document: EP